Vrimolol 12.5 Tablet ER
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Metoprolol Succinate (12.5mg)
Overview Vrimolol 12.5 Tablet ER
Cardiol 12.5mg Extended-Release Tablets are a beta-blocker medication indicated for managing hypertension, angina pectoris, and cardiac arrhythmias. This medication also aids in migraine prophylaxis and reduces the risk of recurrent myocardial infarction and stroke. Cardiol 12.5mg ER may be administered alone or in conjunction with other therapies, with dosage and frequency tailored to individual needs and disease severity. Administer consistently at the same time each day, with or without food, for optimal efficacy. Full therapeutic benefit may take several weeks to manifest, and continuous use may be necessary. Discontinuation may exacerbate underlying conditions. Common, generally mild and transient, adverse effects include fatigue, cephalalgia, depressive mood, diarrhea, skin rash, bradycardia, dizziness, and nausea. Less frequent side effects encompass dyspnea and hypotension. Gradual dose escalation minimizes adverse event risk. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any hepatic impairment. This medication is contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Consult your physician before use during pregnancy or lactation. Individual suitability should be assessed by a healthcare professional. Regular blood pressure monitoring is essential to gauge treatment efficacy. Alcohol consumption should be avoided due to potential exacerbation of adverse effects.
Uses of Vrimolol 12.5 Tablet ER
Managing angina pectoris (chest pain due to heart disease) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Hypertension (high blood pressure) management | Migraine prophylaxis
Major Benefits of Vrimolol 12.5 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vrimolol 12.5 mg Extended Release tablets. Swallow the tablet whole; do not crush, chew, or break it. While you may take this medication with or without food, consistency is key—take it at the same time each day. Limit consumption of high-fat foods, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and meat, while taking Vrimolol 12.5 mg ER.
Common Side effects of Vrimolol 12.5 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Vrimolol 12.5 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vrimolol 12.5 Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and fatty meats while taking Vrimolol 12.5 Tablet ER.
How Vrimolol 12.5 Tablet ER works:
Extended-release Vrimolol 12.5mg tablets are a cardioselective beta-adrenergic blocker, reducing heart rate and improving cardiac output.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vrimolol 12.5 Tablet ER and alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vrimolol 12.5 mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Extended-release Vrimolol 12.5 mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Vrimolol 12.5 mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Vrimolol 12.5 Tablet ER without requiring a change in dosage.
LiverCAUTION
Extended-release Vrimolol 12.5 mg tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Vrimolol 12.5 Tablet ER :
Should you forget a Vrimolol 12.5 Tablet ER dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vrimolol 12.5 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |





